Coverage of GLP-1s for weight loss has become particularly controversial: a 2025 ICER report noted only 18% of large employers cover these drugs ( [26] ), and 3052% of obesity-drug prescriptions were denied by payers as not covered ( [27] )
By understanding the expected timeline and the factors that influence it, you can design a more effective study, manage expectations, and contribute meaningful data to this incredibly exciting field
This dual role mechanism enhances cellular antioxidant capacity, positioning NAC as a promising therapeutic candidate for managing Hg-induced lung toxicity
Because they are not mass-produced in a factory, their storage requirements can be more strict
In particular, two short-acting formulations of Lixisenatide and Exenatide and four long acting preparations of Exenatide, Liraglutide, Dulaglutide and the most recent and successful Semaglutide, were approved in October, 2017 for the North American markets by FDA 1 (185)
Avoid repeated freezethaw cycles: aliquot material into smaller containers before long-term storage
